Category: Cost Alert

Lower the Price

Following today’s earnings report released by Gilead, the manufacturer of Sovaldi, AHIP Spokesman Brendan Buck released the following statement: “It’s time to lower the price of Sovaldi. While it was a blockbuster quarter for Gilead, people who can’t access the drug because of its price didn’t fare nearly as well. Health plans and government programs are covering the vast majority of the cost of Sovaldi, but the price being charged continues to put the drug out of reach for too [...]

Posted in: Cost Alert, Health Care Costs, Uncategorized

Wow, this drug is really expens — Look! A squirrel!!

For years, the pharmaceutical industry has had a pretty simple strategy for discussing the prices it charges for its drugs: don’t. Continue reading

Posted in: Cost Alert, Health Care Costs

A Single Drug: 8% Higher Premiums for Seniors on Medicare

We’ve discussed the astronomically priced hepatitis C drug, Sovaldi, the concern that this is the new normal, and the outrage its pricing has sparked. Continue reading

Posted in: Cost Alert, Health Care Costs

Chart of the Day: Twelve of the Most Expensive Specialty Drugs

“Since 2007, the cost of many of the brand names associated with those drugs has skyrocketed, according to a recent Bloomberg News analysis, with prices in many cases doubling and tripling. ‘While the consumer price index rose just 12 percent in the period,’ Bloomberg reported, ‘one diabetes drug quadrupled in price and another rose by 160 percent.’” Continue reading

Posted in: Cost Alert, Health Care Costs

Chart of the Day: California’s Projected Spending on Sovaldi vs. Spending on Education

“California, for example, might have to spend more on buying Sovaldi for its Medicaid beneficiaries than it currently does on all K-12 and higher education.” Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert

“Lightning Rod” Drug Sparks “Fierce Debate” Over Rx Prices

In health care circles these days, you can’t turn around without hearing about the high cost of specialty pharmaceuticals – in particular the latest hepatitis C drug, Sovaldi. As Vox noted, “the fiercest debate in health care is about a $1,000 pill.” Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert

Spotlight Shines Brightly on Exorbitant Prices of Specialty Drugs

  At its core, the cost of health insurance is a reflection of the cost of health care. That’s why so many are concerned about the skyrocketing price of specialty pharmaceuticals in America. And now, with the indefensibly-priced drug Sovaldi breaking sales records, this scary trend is garnering more and more attention.   CNBC may have put it best this week when it reported, “The mounting scrutiny of prescription drug prices in the U.S. reached fever pitch when a new [...]

Posted in: Cost Alert, Health Care Costs

How Do You Justify “Gravity-Defying” Drug Prices?

The $1,000-a-pill Hepatitis C drug has been at the forefront of the news lately, but that drug isn’t the only one with an astronomical price tag, a Bloomberg article points out. Continue reading

Posted in: Cost Alert, Health Care Costs

Report: Global Spending on Cancer Medicine Hits $91 Billion

A new report on medication costs is bringing to light the high cost of cancer medication. Continue reading

Posted in: Cost Alert, Health Care Costs

What They Are Saying About the $1,000 Pill

Last year alone, U.S. spending on prescription drugs totaled $263.3 billion – 25% of which was spent on specialty drugs. Over the past few months, the spotlight has been on Gilead’s $1,000-a-pill drug, Sovaldi, and future implications for patients and the health system when medications are priced so astronomically high. Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert